In February 2012, EPA established a chronic oral reference dose (RfD) for noncancer effects for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is used as a reference dioxin. In a study published in September 2013, FSIS estimated dietary exposures of its regulated products for comparison to the RfD.